Pure Red Cell Aplasia

DBCOND0028424Hemic and Lymphatic DiseasesImmune System Diseases

Pure Red Cell Aplasia is the indication for 8 drugs in DrugBank. It is covered by 8 curated, structured indications.

Also known as
Red-Cell Aplasia, Pure · Aplasia, pure red cell · pure red cell aplasia (PRCA)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0018667SNOMED CT191252000MedDRA10002965UMLSC0034902

What you can answer from here — as of October 22, 2026

8Indicated drugsWith each drug's targets and mechanism
Listed above
8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
23Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
13Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Pure Red Cell Aplasia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In